title: Anti-CD20 antibodies to treat lymphoproliferative syndromes following renal transplantation.
authors: Department of Nephrology and Internal Medicine, Charles Nicolle Hospital, Tunis, Tunisia. abderrahim.ezzaddine@rns.tn
authors: E
authors: E
authors: Abderrahim
authors: C
authors: C
authors: Karoui
authors: W
authors: W
authors: Smaoui
authors: L
authors: L
authors: Raies
authors: T
authors: T
authors: Ben Abdallah
authors: H
authors: H
authors: Hedri
authors: F
authors: F
authors: Ben Moussa
authors: R
authors: R
authors: Bardi
authors: K
authors: K
authors: Ayed
authors: H Ben
authors: HB
authors: Maïz
mesh_terms: D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology; D018951:Antigens, CD20 / Q000276:immunology*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D016393:Lymphoma, B-Cell / Q000628:therapy*; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy; D013125:Spinal Neoplasms / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D018951:Antigens, CD20